Home
Charts
Search
Watchlist
Products
All IPOs
₹54 - 54
Galaxy Medicare Ltd
HealthcareIPOSME
₹54 - 54
Our Company Galaxy Medicare Limited is into the manufacturing, trading and exporting of Medical Devices, Plasters of Paris Bandages (POP Bandage) and Other surgical dressings in India.
Lot2,000Min Invest₹2,16,000Face Value₹10Issue Size₹22 CrFresh Issue₹18 CrOffer for Sale₹4 CrListing Price₹54CMP₹18
Timeline
10 Sept
Bidding opens
12 Sept
Bidding closes
15 Sept
Allotment
16 Sept
Refund & demat credit
17 Sept
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹22 Cr0.41 Cr shares
Fresh Issue₹18 Cr
Offer for Sale₹4 Cr
Face Value₹10
Lot Size2,000 shares
ReservationQIB 2.04% · NII 39.14% · RETAIL 58.82%
Application Sizes
Retail₹2,16,0001-1 lots
sNII₹2,16,000from 2 lots
bNII₹10,80,000from 10 lots
Managers & Registrar
Lead ManagerAffinity Global Capital Market Pvt Ltd
RegistrarCameo Corporate Services Ltd
Ownership & Proceeds
Offer for Sale
Selling ShareholderShares OfferedAmt ₹ CrDillip Kumar DasPRMTR8,24,0004.45Total8,24,0004.45
Shareholding
CategoryPre IPOPost IPOPromoter Group99.57%72.48%Public0.43%27.52%
Objects of the Issue
- Funding capital expenditure requirement towards purchase of machinery for the company existing manufacturing facility at
- Funding the working capital requirements
- General corporate purposes
Financials
Profit & Loss
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| RevenueCr | 30 | 31 | 36 | 39 | 40 |
| Operating ProfitCr | 2 | 2 | 5 | 5 | 4 |
| OPM% | 8.2 | 7.2 | 13.6 | 11.9 | 10.6 |
| PBTCr | 0 | 2 | 5 | 5 | 5 |
| PATCr | 0 | 2 | 4 | 3 | 3 |
| EPS | -1 | 5 | 3 | 3 | 2 |
Balance Sheet
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Equity CapitalCr | 3 | 3 | 12 | 12 | 15 |
| ReservesCr | 13 | 15 | 10 | 12 | 25 |
| BorrowingsCr | 10 | 9 | 8 | 5 | 4 |
| Total AssetsCr | 30 | 32 | 33 | 31 | 49 |
Cash Flow
| Financial Year | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Operating Cash FlowCr | -1 | 4 | 3 | 4 | 2 |
| Investing Cash FlowCr | -1 | -2 | -1 | 0 | -14 |
| Financing Cash FlowCr | 1 | -2 | -2 | -5 | 12 |
| Net Cash FlowCr | 0 | 0 | 0 | 0 | 0 |
Strengths & Risks
Strengths · as stated in the DRHP
- Organizational stability along with management expertise.
- Established reputation and customer relationships.
- Focus on consistently meeting quality standards.
- International Presence.
- Well Established Manufacturing Facility designed for wide range of products.
- Experienced Management Team and a motivated and efficient workforce.
Strategies · as stated in the DRHP
- Building our relationship with industry leading OEM's i.e. Principal to Principal and diversifying our customer base by expanding our business in medical device and surgical dressings products.
- Strengthening our business through effective branding, promotional and digital marketing activities.
- Focus on Increase in Products range and Volume of Sales.
- Reduction of operational costs and achieving efficiency.
- Focus on consistently meeting quality standards.
Risks · as stated in the DRHP
- The company is supplying to certain key customers, from whom its derives a significant portion of the company revenues. The loss of any significant customer may have a material and adverse effect on its business and results of operations.
- The comapny is highly dependent on its suppliers for uninterrupted supply of Raw-Materials. Any shortfall in the supply of the raw materials, or an increase in its raw material costs and other input costs, may adversely affect the pricing and supply of the products with subsequently having an adverse effect on the business, results of operations and financial conditions of the company.
- The Company, the Directors, and the Promoters is parties to certain legal proceedings. Any adverse decision in such proceedings may have adverse effect on its business, prospects, results of operations and financial condition.
- There have been instances of delay in filing of Goods and Service Tax (GST) returns, Employee State Insurance (ESI) Returns, return of Tax Deducted at Source (TDS) dues and in payment of Provident Fund dues.
- Inventories and trade receivables form a major part of the current assets. Failure to manage the company inventory and trade receivables could has an adverse effect on its net sales, profitability, cash flow and liquidity.
- The company is dependent on its promoters and senior management and other key personnel, and the loss of, or its inability to attract or retain, such persons could affect of the business, results of operations, financial condition and cash flows.